Brockman Mining (159) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
10 Dec, 2025Executive summary
Recorded a net loss after tax of HK$13.4 million for FY2024, a significant improvement from HK$56.6 million in FY2023, mainly due to lower exploration and evaluation expenses and finance income from remeasurement of payables and loans.
No revenue was generated during the year; operations focused on iron ore project development and exploration in Western Australia.
The Marillana and Ophthalmia projects, both 50% owned, remain the core assets, with technical studies and environmental approvals progressing.
Financial highlights
Operating loss reduced to HK$24.3 million from HK$66.7 million year-over-year, driven by lower exploration expenses.
Basic and diluted loss per share improved to HK$0.14 cents from HK$0.61 cents year-over-year.
Net asset value at 30 June 2024 was HK$498.5 million (2023: HK$511.2 million); cash at bank was HK$4.5 million (2023: HK$16.5 million).
Total comprehensive loss for the year was HK$12.7 million, down from HK$78.9 million in FY2023.
No dividend was declared or paid for the year.
Outlook and guidance
Directors believe sufficient financial resources are available for the next 12 months, supported by extended and increased shareholder loan facilities.
Ongoing focus on advancing Marillana and Ophthalmia projects toward development, subject to funding and regulatory approvals.
Material uncertainty remains regarding the Group’s ability to continue as a going concern, as highlighted by the auditor.
Latest events from Brockman Mining
- Net loss narrowed, no revenue, project advancement ongoing, funding and approvals remain key risks.159
H1 202625 Feb 2026 - Net loss rose to HK$19.5M as cash fell and project progress depends on funding and approvals.159
H1 202510 Dec 2025 - Net loss widened to HK$34.6 million as project development advanced amid funding uncertainty.159
H2 202517 Sep 2025 - Marillana Project and port development advanced, with strong funding runway and pending approvals.159
Q4 2024 TU13 Jun 2025